Bowen Hanes & CO Inc Compugen LTD Transaction History

Bowen Hanes & CO Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$7.67 - $13.77 $5.22 Million - $9.36 Million	-680,000 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$12.07 - $17.95 $362,100 - $538,500	30,000 Added 4.62%	680,000 $8.24 Million
Q3 2020 Nov 02, 2020	BUY	$14.16 - $19.45 $9.2 Million - $12.6 Million	650,000 New	650,000 $10.6 Million

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $126M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Bowen Hanes & CO Inc with notifications on news.